Title : Changes in serum transforming growth factor-β1 levels in chronic hepatitis C patients under antiviral therapy.

Pub. Date : 2016 Jan-Mar

PMID : 26752952






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: Our data show that TGF-beta1 serum levels decrease significantly at the EOT and remain decreased 6 months after the EOT mostly in chronic hepatitis C patients who achieve SVR after pegylated interferon-alpha and ribavirin combination treatment. Ribavirin transforming growth factor beta 1 Homo sapiens